Your browser doesn't support javascript.
loading
Landscape fire smoke airway exposure impairs respiratory and cardiac function and worsens experimental asthma.
Gomez, Henry M; Haw, Tatt J; Ilic, Dusan; Robinson, Peter; Donovan, Chantal; Croft, Amanda J; Vanka, Kanth S; Small, Ellen; Carroll, Olivia R; Kim, Richard Y; Mayall, Jemma R; Beyene, Tesfalidet; Palanisami, Thava; Ngo, Doan T M; Zosky, Graeme R; Holliday, Elizabeth G; Jensen, Megan E; McDonald, Vanessa M; Murphy, Vanessa E; Gibson, Peter G; Horvat, Jay C.
Afiliação
  • Gomez HM; School of Biomedical Sciences and Pharmacy, University of Newcastle and Immune Health Program, Hunter Medical Research Institute, Newcastle, Australia.
  • Haw TJ; Heart and Stroke Research Program, Hunter Medical Research Institute, New Lambton Heights, Newcastle, Australia; College of Health, Medicine, and Wellbeing, Centre of Excellence Newcastle Cardio-Oncology Research Group, University of Newcastle, Callaghan, Newcastle, Australia.
  • Ilic D; Newcastle Institute for Energy and Resources, University of Newcastle, Callaghan, Australia.
  • Robinson P; Newcastle Institute for Energy and Resources, University of Newcastle, Callaghan, Australia.
  • Donovan C; School of Biomedical Sciences and Pharmacy, University of Newcastle and Immune Health Program, Hunter Medical Research Institute, Newcastle, Australia; School of Life Sciences, University of Technology Sydney, Faculty of Science, Sydney, Australia.
  • Croft AJ; Heart and Stroke Research Program, Hunter Medical Research Institute, New Lambton Heights, Newcastle, Australia; College of Health, Medicine, and Wellbeing, Centre of Excellence Newcastle Cardio-Oncology Research Group, University of Newcastle, Callaghan, Newcastle, Australia.
  • Vanka KS; School of Biomedical Sciences and Pharmacy, University of Newcastle and Immune Health Program, Hunter Medical Research Institute, Newcastle, Australia; Newcastle Institute for Energy and Resources, University of Newcastle, Callaghan, Australia.
  • Small E; School of Biomedical Sciences and Pharmacy, University of Newcastle and Immune Health Program, Hunter Medical Research Institute, Newcastle, Australia.
  • Carroll OR; School of Biomedical Sciences and Pharmacy, University of Newcastle and Immune Health Program, Hunter Medical Research Institute, Newcastle, Australia.
  • Kim RY; School of Biomedical Sciences and Pharmacy, University of Newcastle and Immune Health Program, Hunter Medical Research Institute, Newcastle, Australia; School of Life Sciences, University of Technology Sydney, Faculty of Science, Sydney, Australia.
  • Mayall JR; School of Biomedical Sciences and Pharmacy, University of Newcastle and Immune Health Program, Hunter Medical Research Institute, Newcastle, Australia.
  • Beyene T; School of Medicine and Public Health, University of Newcastle and Asthma and Breathing Program, Hunter Medical Research Institute, Newcastle, Australia.
  • Palanisami T; Global Innovative Centre for Advanced Nanomaterials, University of Newcastle, Callaghan, Australia.
  • Ngo DTM; Heart and Stroke Research Program, Hunter Medical Research Institute, New Lambton Heights, Newcastle, Australia; College of Health, Medicine, and Wellbeing, Centre of Excellence Newcastle Cardio-Oncology Research Group, University of Newcastle, Callaghan, Newcastle, Australia.
  • Zosky GR; Menzies Institute for Medical Research, College of Health and Medicine, University of Tasmania, Hobart, Australia; College of Health and Medicine, Tasmanian School of Medicine, University of Tasmania, Hobart, Australia.
  • Holliday EG; School of Medicine and Public Health, University of Newcastle, Callaghan, Australia.
  • Jensen ME; School of Medicine and Public Health, University of Newcastle and Asthma and Breathing Program, Hunter Medical Research Institute, Newcastle, Australia.
  • McDonald VM; School of Medicine and Public Health, University of Newcastle and Asthma and Breathing Program, Hunter Medical Research Institute, Newcastle, Australia.
  • Murphy VE; School of Medicine and Public Health, University of Newcastle and Asthma and Breathing Program, Hunter Medical Research Institute, Newcastle, Australia.
  • Gibson PG; School of Medicine and Public Health, University of Newcastle and Asthma and Breathing Program, Hunter Medical Research Institute, Newcastle, Australia.
  • Horvat JC; School of Biomedical Sciences and Pharmacy, University of Newcastle and Immune Health Program, Hunter Medical Research Institute, Newcastle, Australia. Electronic address: jay.horvat@newcastle.edu.au.
J Allergy Clin Immunol ; 154(1): 209-221.e6, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38513838
ABSTRACT

BACKGROUND:

Millions of people are exposed to landscape fire smoke (LFS) globally, and inhalation of LFS particulate matter (PM) is associated with poor respiratory and cardiovascular outcomes. However, how LFS affects respiratory and cardiovascular function is less well understood.

OBJECTIVE:

We aimed to characterize the pathophysiologic effects of representative LFS airway exposure on respiratory and cardiac function and on asthma outcomes.

METHODS:

LFS was generated using a customized combustion chamber. In 8-week-old female BALB/c mice, low (25 µg/m3, 24-hour equivalent) or moderate (100 µg/m3, 24-hour equivalent) concentrations of LFS PM (10 µm and below [PM10]) were administered daily for 3 (short-term) and 14 (long-term) days in the presence and absence of experimental asthma. Lung inflammation, gene expression, structural changes, and lung function were assessed. In 8-week-old male C57BL/6 mice, low concentrations of LFS PM10 were administered for 3 days. Cardiac function and gene expression were assessed.

RESULTS:

Short- and long-term LFS PM10 airway exposure increased airway hyperresponsiveness and induced steroid insensitivity in experimental asthma, independent of significant changes in airway inflammation. Long-term LFS PM10 airway exposure also decreased gas diffusion. Short-term LFS PM10 airway exposure decreased cardiac function and expression of gene changes relating to oxidative stress and cardiovascular pathologies.

CONCLUSIONS:

We characterized significant detrimental effects of physiologically relevant concentrations and durations of LFS PM10 airway exposure on lung and heart function. Our study provides a platform for assessment of mechanisms that underpin LFS PM10 airway exposure on respiratory and cardiovascular disease outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Fumaça / Material Particulado / Camundongos Endogâmicos BALB C Limite: Animals Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Fumaça / Material Particulado / Camundongos Endogâmicos BALB C Limite: Animals Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália